北京地区基层医疗机构中成药处方点评共识报告(2018版)

Beijing consensus report on prescription review of Chinese patent medicines in primary medical and health care institutions(version 2018)

基层医疗机构的中成药品种数和临床使用日益增长,合理用药问题日趋突出,但目前缺少适用于基层医疗机构中成药处方合理性评价的技术规范和指导。针对这一亟须解决的问题,北京市卫计委基层医疗机构处方点评工作组中成药学组会同北京市10余家二、三级医院的一线临床中药师,在前期工作和现有认识基础上,编写了本共识。本共识的编写遵循中华医学会、中华中医药学会关于指南编写的建议,参考国内外权威、常用的Delphi专家咨询法和GRADE证据评价系统,采取最新的共识报告形式完成。最终形成的共识涉及点评工作的组织管理、适应证和遴选药品点评、用法用量和疗程点评、联合用药点评4部分共27条"陈述",为基层医疗机构的中成药处方点评提供技术参考和学术指导。

With the increasing varieties of Chinese patent medicines and their clinical use in primary medical and health care institutions,the problem of reasonable use is getting worse.Currently,there is a lack of technical specifications and guidance for evaluating the rationality of Chinese patent medicine prescriptions.Aiming at this problem,this consensus report is written on the basis of previous work and existing knowledge,by the primary medical institution prescription review working group（Traditional Chinese Medicine）of Beijing Municipal Commission of Health and Family Planning,and the first-line clinical pharmacists of more than 10 secondary and tertiary hospitals in Beijing.This consensus report is prepared in accordance with the recommendations of Chinese Medical Association and China Association of Chinese Medicine on the preparation of guidelines,referring to the authoritative and commonly used Delphi expert consultation and GRADE evidence evaluation system,and taking the latest consensus report as its final form.The final consensus involves 4 sections with a total of 27＂statements＂,including the organization and management of the prescription review work,the review of indication and drug selection,the review of Usage,dosage and course of treatment,and the review of drug combination.It is hoped that this consensus report can provide the technical specification and academic guidance for the prescription review of Chinese patent medicines in primary medical and health care institutions.